Cethromycin

喹红霉素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameCethromycin
Drug Alias NameCetromicina塞红霉素CethromycinumRestanzaA-195773.0 +[7
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitorsProtein biosynthesis inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsPneumonia

Other Information

ATC CodeN/A